Harvard Bioscience (HBIO) Other Non-Current Assets (2010 - 2026)

Harvard Bioscience (HBIO) has 17 years of Other Non-Current Assets data on file, last reported at $2.6 million in Q1 2026.

• On a quarterly basis, Other Non-Current Assets fell 26.59% year-over-year to $2.6 million in Q1 2026; TTM through Mar 2026 was $2.6 million, a 26.59% decrease from a year earlier, with the FY2025 full-year figure at $2.7 million, down 5.08% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $2.6 million, down from $2.7 million in the prior quarter.
• Over the last five years, Other Non-Current Assets for HBIO reached as high as $8.7 million in Q2 2022 and fell as low as $2.6 million in Q1 2026.
• Historically, Other Non-Current Assets has averaged $5.2 million across 5 years, with a median of $4.8 million in 2024.
• Across the five-year window, Other Non-Current Assets soared 1047.24% in 2022 and sank 61.08% in 2024, its largest moves.
• Year by year, Other Non-Current Assets stood at $7.8 million in 2022, then slipped by 16.8% to $6.5 million in 2023, then plunged by 56.23% to $2.8 million in 2024, then retreated by 5.08% to $2.7 million in 2025, then slipped by 3.98% to $2.6 million in 2026.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $2.6 million in Q1 2026, $2.7 million in Q4 2025, and $3.8 million in Q3 2025.